CClinicalTrials.gg
Sign In
Status unknownNCT02474511Updated Jun 17, 2015

the Influence of General Anesthesia on Tumor Metastasis and Recurrence

An observational study in Tumor Recurrence and Metastasis, sponsored by RenJi Hospital. Status unknown at 1 site in China. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2015-06-17.

Sponsored by RenJi Hospital · Observational

The sponsor has not verified this record recently (last verified Jun 2015), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
300
Ages
18 Years to 65 Years
Sex
All
01

Study summary

The purpose of this study was to investigate whether general anesthesia will affect the postoperative recurrence and metastasis of malignant tumor.

02

Conditions studied

  • Tumor Recurrence and Metastasis
03

In context

Neoplasm Metastasis

3,517 studies on the registry are indexed under Neoplasm Metastasis; 885 are open to participants now.

This study's planned enrollment of 300 is above the median of 121 across 594 observational studies indexed under Neoplasm Metastasis.

Browse Neoplasm Metastasis studies →

Lead sponsor

RenJi Hospital is the lead sponsor of 535 studies on the registry; 244 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

the patient with primary liver cancer.

Inclusion criteria

  • ASA I - III Primary liver cancer tumor is single and diameter is less than 3 centimeter There is no major vascular invasion phenomenon, no lymph nodes or extrahepatic metastases The Child - Pugh belong to type A or type B

Exclusion criteria

Exclusion Criteria:

  • Had a history of liver surgery (including radiofrequency ablation) Severe disease of heart, lung, kidney, the immune system INR > 1.5 or platelet count is less than 45000 cells/mm3 History of opioid addiction Metastatic liver tumors Not sure of primary liver cancer Don't agree to participate in this experiment
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
300 participants (estimated)
Patient registry
No
Biospecimen retention
Samples without dna

Groups and cohorts

  • general anesthesia

    In this group，the patient is received radiofrequency ablation under general anesthesia.

    Other: general anesthesia and local anesthesia

  • local anesthesia

    In this group，the patient is received radiofrequency ablation under local anesthesia.

    Other: general anesthesia and local anesthesia

Interventions

  • Othergeneral anesthesia and local anesthesia

    the patient received generalanesthesia and local anesthesia randomly

06

What researchers measure

Primary outcomes

  1. Number of participants with tumor recurrence and metastasis

    Follow-up of patients with tumor recurrence and metastasis after Radiofrequency ablation to 3 years

    Time frame: 3 years

07

Study locations

1 of 1 sites recruiting
  • Shanghai Renji Hospital
    Shanghai, Shanghai 200127, China
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 17, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02474511
Lead sponsor
RenJi Hospital
Responsible party
Sponsor
First posted
Jun 17, 2015
Start date
Jun 2015
Primary completion
Jun 2018 (estimated)
Completion
Apr 2019 (estimated)
Last update
Jun 17, 2015

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jun 2015. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Neoplasm Metastasis→

Other studies from this sponsor

RenJi Hospital

Start the discussion